Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Chenglong Han

7PUBLICATIONS

26CO-AUTHORS

Clinical neuropsychologySystems physiologyHealth psychologyGeriatrics and gerontologyShip and platform structures (incl. maritime hydrodynamics)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Feb 22, 2024

Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis.

Jeffrey R Curtis, Iain B McInnes, Proton Rahman

|Nov 14, 2023

Qualitative and psychometric evaluation of the PROMIS®-Fatigue SF-7a scale to assess fatigue in patients with moderately to severely active inflammatory bowel disease.

Brian G Feagan, William J Sandborn, Bruce E Sands

|Jul 15, 2021

Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response-results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis.

Proton Rahman, Philip J Mease, Philip S Helliwell

|Sep 10, 2020

Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study.

Kristian Reich, April W Armstrong, Peter Foley

|Jul 15, 2020

Continuous treatment with guselkumab maintains clinical responses through 4 years in patients with moderate-to-severe psoriasis: results from VOYAGE 1.

Christopher E M Griffiths, Kim A Papp, Michael Song

|Jul 16, 2019

Guselkumab improves work productivity in patients with moderate-to-severe psoriasis with or without depression and anxiety: results from the VOYAGE 2 comparator study versus adalimumab.

Kristian Reich, Peter Foley, Chenglong Han

Pageof 2

Frequent Collaborators

2 joint publications

Kristian Reich

2 joint publications

Peter Foley

2 joint publications

April W Armstrong

1 joint publications

Laura K Ferris

1 joint publications

Elyssa Ott

1 joint publications

Jingzhi Jiang

1 joint publications

H Chih-Ho Hong

1 joint publications

Shu Li

1 joint publications

Wojciech Baran

1 joint publications

Christopher E M Griffiths

Frequent Collaborators

2 joint publications

Kristian Reich

2 joint publications

Peter Foley

2 joint publications

April W Armstrong

1 joint publications

Laura K Ferris

Top Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on : Jul 11, 2013

Measuring Psoriasis Severity at Home

Measuring Psoriasis Severity at Home

Published on : Mar 01, 2024

See more related videos

Top Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on : Jul 11, 2013

Measuring Psoriasis Severity at Home

Measuring Psoriasis Severity at Home

Published on : Mar 01, 2024

See more related videos